Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-035112
Filing Date
2015-06-02
Accepted
2015-06-02 16:51:01
Documents
1
Period of Report
2015-06-01

Document Format Files

Seq Description Document Type Size
1 form474757_20150602044939-.html 4  
1 form474757_20150602044939-.xml 4 3572
  Complete submission text file 0001144204-15-035112.txt   5035
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 425 METRO PLACE NORTH STE 400 DUBLIN OH 43017
Business Address
LARSON BRENT L (Reporting) CIK: 0001195766 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 15907494